Oxygen News and Research

RSS

Study confirms impact of high-quality CPR on improving sudden cardiac arrest survival rates

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that results from the CIRC trial were presented at the American Heart Association (AHA) 2011 Resuscitation Science Symposium (ReSS) this weekend in Orlando.

14 Nov 2011

Bone-marrow derived cells do not improve heart function after attack

NIH-funded trial shows that therapy with bone-marrow derived cells does not improve heart function after six months; future clinical benefits still possible.

14 Nov 2011

SANUWAVE Health third quarter revenues decrease 42% to $161,678

SANUWAVE Health, Inc. today reported financial results for the three and nine months ended September 30, 2011.

14 Nov 2011

Combination of REGN910 and aflibercept inhibits tumor angiogenesis in animal models

Combining the investigational agents REGN910 and aflibercept yielded statistically significant improvements in antitumor effects in animal models compared with either agent alone, according to results presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, held Nov. 12-16, 2011.

14 Nov 2011

Researchers retrace evolution of unusual bacterial infection

Researchers at Harvard Medical School and Children's Hospital Boston have retraced the evolution of an unusual bacterial infection as it spread among cystic fibrosis patients by sequencing scores of samples collected during the outbreak, since contained.

14 Nov 2011

Damaged mitochondria equivalent to an environmental disaster in the cell

Current thinking about Parkinson's disease is that it's a disorder of mitochondria, the energy-producing organelles inside cells, causing neurons in the brain's substantia nigra to die or become impaired.

11 Nov 2011

Study: Primary visual cortex is modulated only by attention

In everyday life, attention and awareness appear tightly interwoven. Attending to the scissors on the rinumber of behavioural observations have recently led scientists to postulate that attention and awareness are fundamentally different processes and not necessarily connected.ght side of your desk, you become aware of their attributes, for example the red handles. Vice versa, the red handles could attract your attention to the scissors.

11 Nov 2011

Maryland anesthesiologist named 2011 Researcher of the Year

Often on the mind of Gary Fiskum, PhD, are the more than 250,000 people in the U.S. who get resuscitated from cardiac arrest each year, the 6 million living with traumatic brain injuries, and the wounded warriors whose brain whose brains sustain enormous G-forces from roadside bombs in the war zone.

9 Nov 2011

Brain hypoxia associated with poor short-term outcome after severe TBI

Low oxygen supply (hypoxia) to vulnerable brain tissue is a major contributor to the risk of death or major disability after severe traumatic brain injury (TBI), reports a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

9 Nov 2011

Johns Hopkins researchers unravel how breast cancer metastasizes

The spread of breast cancer is responsible for more than 90 percent of breast cancer deaths. Now, the process by which it spreads—or metastasizes—has been unraveled by researchers at Johns Hopkins. Reporting in two papers, the researchers have discovered the switch that enables breast cancer cells to travel to and be received in the lungs.

9 Nov 2011

Study reveals need for defining optimal amount of iron in infant formula

A 10-year follow-up study examining iron-fortified vs. low-iron infant formula suggests that infants with high hemoglobin levels who received iron fortified infant formula have poorer long-term developmental outcomes.

9 Nov 2011

Inova Labs secures $17.5M in Series B round of equity financing

Inova Labs, a privately held medical device company focused on developing innovative products for the Chronic Obstructive Pulmonary Disease (COPD) market, announced today that it has secured a Series B round of equity financing for up to $17.5M from an investment syndicate led by Latterell Venture Partners, based in San Francisco, Calif.

9 Nov 2011

HUOH pays $3,500,000 in dividends to Ohio doctor owners/insureds in the last 40 months

HUOH is committed to its policyholders and their professional reputation by having a "zero tolerance" for nuisance claims and unparalleled aggressive defense programs for its physicians. Once again, continuing to build on its success from 2010, HUOH is attracting extraordinary physicians, managing claims exceptionally and now delivering another dividend to its' Ohio physician owners of $1,000,000.

8 Nov 2011

Researchers match protein to the job it performs in human body

Scientists at Rochester Institute of Technology and Dowling College are engaged in a similar game with higher stakes. Instead of cards, they are matching the protein to the job it performs in the human body. Their research could lead to drugs that target proteins and switch on or off specific functions associated with various diseases.

8 Nov 2011

Researchers discover key mechanism responsible for degrading ubiquitinated protein aggregates

Researchers at the RIKEN Brain Science Institute (BSI) have discovered a key mechanism responsible for selectively degrading aggregates of ubiquitinated proteins from the cell.

7 Nov 2011

Scientists achieve major step toward goal of producing synthetic Taxol

Taxanes are a family of compounds that includes one of the most important cancer drugs ever discovered, Taxol, among other cancer treatments. But the difficulty producing these complex molecules in the lab has hampered or blocked exploration of the family for further drug leads. Now, a group of Scripps Research Institute scientists has successfully achieved a major step toward the goal of synthetically producing Taxol and other complex taxanes on a quest to harness chemical reactions that could enable research on previously unavailable potential drugs.

7 Nov 2011

PKM2 enzyme has important non-metabolic functions in cancer formation

The embryonic enzyme pyruvate kinase M2 (PKM2) has a well-established role in metabolism and is highly expressed in human cancers. Now, a team led by researchers at the University of Texas MD Anderson Cancer Center reports in advance online publication of the journal Nature that PKM2 has important non-metabolic functions in cancer formation.

7 Nov 2011

Anti-TNFs, methotrexate may reduce risk of cardiovascular disease in people with RA

Taking methotrexate or anti-TNFs is associated with a reduction in risk of cardiovascular disease in people with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

7 Nov 2011

Teleflex to showcase respiratory solutions, education programs at AARC Congress

Teleflex Incorporated will showcase a number of respiratory solutions and education programs at the annual American Association of Respiratory Care Congress to be held in Tampa, Florida on November 5-8, 2011.

5 Nov 2011

Sensor system can monitor heart rate, skin conductance while driving

Safety in traffic depends on a number of factors. One decisive aspect is how fit the driver is. A research team at the Technische Universitaet Muenchen (TUM), in collaboration with researchers at the BMW Group, managed to develop a sensor system integrated into the steering wheel that can monitor the driver's state of health while driving.

4 Nov 2011